Alzheimer's disease is a progressive, irreversible neurodegenerative disease impacting
cognition, function, and behavior. Alzheimer's disease progresses along a continuum from …

Virtually all adults with Down syndrome (DS) show the neuropathological changes of
Alzheimer disease (AD) by the age of 40 years. This association is partially due to …

People who have survived COVID-19 frequently complain of cognitive dysfunction, which
has been described as brain fog. The prevalence of post–COVID-19 cognitive impairment …

Non-invasive Gamma ENtrainment Using Sensory stimulation (GENUS) at 40Hz reduces
Alzheimer's disease (AD) pathology such as amyloid and tau levels, prevents cerebral …

Introduction Although dementia prevalence differs by race, it remains unclear whether
cognition and neuropsychiatric symptom severity differ between Black and White individuals …

Methods: UDS Version 3 was developed after years of coordination between the National
Institute on Aging-appointed Clinical Task Force (CTF), clinicians from∼ 30 ADCs, and the …

Introduction There is an urgent need to validate telephone versions of widely used general
cognitive measures, such as the Montreal Cognitive Assessment (T‐MoCA), for remote …

Background There is a limited understanding of the cognitive and psychiatric sequelae of
COVID-19 during the post-acute phase, particularly among racially and ethnically diverse …

Significant progress has been made in understanding the pre-symptomatic phase of
amyotrophic lateral sclerosis. While much is still unknown, advances in other …

At present, no research criteria exist for the diagnosis of prodromal behavioural variant
frontotemporal dementia (bvFTD), though early detection is of high research importance …